• 제목/요약/키워드: National Safety Assessment

검색결과 1,693건 처리시간 0.031초

KURT 환경 자료를 이용한 가상의 다중 발생원에서의 누출 핵종의 이동 시간 평가 (Travel Times of Radionuclides Released from Hypothetical Multiple Source Positions in the KURT Site)

  • 고낙열;정종태;김경수;황영택
    • 방사성폐기물학회지
    • /
    • 제11권4호
    • /
    • pp.281-291
    • /
    • 2013
  • KURT(KAERI Underground Research Tunnel) 부지 부근에 가상의 처분장을 설정하고, 해당 부지의 세 지점에서 방사성폐기물로부터 누출된다고 가정한 방사성 핵종의 이동 시간을 계산하였다. 핵종의 이동 경로는 핵종 누출 지점에서 천부 지하수대까지로 설정하고 KURT 주변 지하수 유동계 모의를 통해 결정하였다. 세 지점은 지하수가 빠르게 유동하는 구조(highly water-conductive feature)를 지나가기 때문에 천부 지하수까지 도달하는데 상대적으로 적은 시간이 걸리는 지점으로 선정되었다. 핵종의 이동 시간은 TDRW(Time-Domain Random Walk) 기법을 통해 계산하였다. 지하수 내의 핵종의 이동 시간을 계산하기 위해, 이류(advection)와 분산(dispersion) 이외에 암반 기질(rock matrix)로의 확산(diffusion)과 기질 내부에서의 흡착(sorption)이 고려되었고, 핵종의 붕괴 및 변환에 의한 영향도 몇 개의 붕괴 사슬(decay chain)을 이용하여 계산에 반영하였다. 계산 결과를 보면, 지표 부근의 천부 지하수에 도달하는 핵종의 시간당 이동량(mass flux)은 복수의 이동 경로뿐만 아니라 핵종의 반감기와 암반 기질 내에서의 핵종의 흡착 분배 계수에 크게 영향을 받는 것으로 나타났다. 따라서 보다 안정적이고 불확실성이 감소된 심지층 처분장의 안전성 평가를 위해 우선적으로 필요한 사항으로는, 장반감기 핵종에 대한 평가가 이동 과정 이외에 저장 용기에 들어있는 상태에서부터 면밀하게 이루어져야 하고, 암반 기질에서 발생하는 핵종의 흡착 과정이 심부 현장 조건을 반영하여 평가되어야 할 것으로 생각된다.

Effectiveness and Safety of Mechanical Thrombectomy with Stent Retrievers in Basilar Artery Occlusion : Comparison with Anterior Circulation Occlusions

  • Hu, Soo Young;Yi, Ho Jun;Lee, Dong Hoon;Hong, Jae Taek;Sung, Jae Hoon;Lee, Sang Won
    • Journal of Korean Neurosurgical Society
    • /
    • 제60권6호
    • /
    • pp.635-643
    • /
    • 2017
  • Objective : Acute basilar artery occlusion (BAO) is associated with severe neurological dysfunction and high mortality rates. The benefits of mechanical thrombectomy in BAO have not been explored in recent clinical trials. Therefore, we analyzed outcomes of stent retriever mechanical thrombectomy for BAO, and compared with anterior circulation occlusions (ACO). Methods : In total, 161 consecutive patients (24 BAO, 137 ACO) who underwent mechanical thrombectomy with the stent retriever between January 2013 and August 2016 enrolled in our study. All patients underwent clinical assessment with the National Institutes of Health Stroke Scale (NIHSS) and modified Rankin scale (mRS). Radiological results were used to evaluate thrombolysis in cerebral infarction (TICI) scores and successful recanalization was defined by TICI 2b or 3. Results : Mean NIHSS scores at 24 hours and 30 days were significantly higher in the BAO group than the ACO group (p=0.021, p=0.001). mRS at 90 days was significantly higher in the BAO group (4.2) compared with the ACO group (3.0) (p=0.003). The BAO group (2.0) performed fewer stent retriever passages than the ACO group (2.7) (p=0.049). There were no significant differences between the two groups in terms of complications, but the BAO patients experienced a higher mortality (16.6%) rate than ACO patients (5.8%) (p=0.001). In subgroup analysis of BAO, patients with short procedure times achieved successful recanalization (p=0.001) and successfully recanalized patients exhibited more favorable mRS at 90 days (p=0.027). Conclusion : In our study, mechanical thrombectomy of BAO patients showed worse clinical outcome and higher mortality rate than ACO patients. However, mechanical thrombectomy with a stent retriever in BAO is an effective treatment, because successfully recanalized patients showed good clinical outcome in BAO patients.

Assessment of Airborne Welding Fume Concentration for Some Manufacturing Industries in Busan

  • Cha, Min-Ho;Kim, Jeong-Won;Kim, Jong-Eun;Cho, Young-Ha;Moon, Deog-Hwan
    • 한국환경보건학회지
    • /
    • 제33권6호
    • /
    • pp.506-512
    • /
    • 2007
  • This study was conducted to describe the exposure levels of welding fumes by the type of manufacturers, work process, welding type and the size of manufacturers, and to find out the trend of chronological changes of airborne welding fume levels. The subjects of this study were 509 manufacturers, consisting of 11 types of manufacturers, 3 work processes, 7 welding types, in Busan from January, 1997 to December, 2005. Airborne concentration of welding fume was determined by manual of National Institute for Occupational Safety and Health (NIOSH), and the data were analyzed by using SPSS 10.0 for Windows program. The mean concentration of airborne welding fume in all manufacturers was $1.29\;mg/m^3$ (Range: $0.01{\sim}3.00\;mg/m^3)$. The level of welding fume was the highest, as $1.96\;mg/m^3$, for manufactures of motor vehicles, trailers and semi-trailers, which was lower than $5.0\;mg/m^3$ of 8 hr-TWA in Korean permissible exposure limit for welding fume. There was a significant difference in the mean levels of welding fumes by work process, showing the highest in welding workshop ($1.39\;mg/m^3$), followed by pipeline welding workshop ($1.26\;mg/m^3$) and engineering workshop ($1.20\;mg/m^3$). Among welding types, the mean level of welding fume was the highest in the type of $CO_2$ & arc welding, as $1.46\;mg/m^3$, followed by $CO_2$ welding ($1.40\;mg/m^3$), shielded metal arc welding ($1.31\;mg/m^3$), spot welding ($1.27\;mg/m^3$), and so on. The highest mean level of welding fume was $1.58\;mg/m^3$ in work process of pipe line welding workshop for the manufacturers of basic iron and steel, and $2.27\;mg/m^3$ in the type of arc welding for the manufactures building ship and boats. By the size of manufacturers, the mean concentration of welding fume for manufactures in small scale with less than 50 workers was the highest as $1.45\;mg/m^3$ (Range: $0.07{\sim}3.00\;mg/m^3)$. The mean level of welding fume was the highest as $1.39\;mg/m^3$ both in 1997 and in 2005, showing a trend of fluctuating periodically within a range of $1.10{\sim}1.39\;mg/m^3$. The above results suggested that more effective control program for work environment producing welding fumes should be developed and applied since there were significant variations in welding fume levels by the type of manufacturers, work processes, welding types, the size of manufactures, and by year.

아토피 피부염의 한약 치료에 대한 무작위대조군연구 중심의 연구 동향 - CNKI를 중심으로 (Research Trends of Randomized Controlled Trials on Herbal Medicine Treatment for Atopic Dermatitis-Focusing on CNKI)

  • 양금진;조은희;강수진;홍지은;심유화;이주현;박민철
    • 동의생리병리학회지
    • /
    • 제34권2호
    • /
    • pp.102-116
    • /
    • 2020
  • The purpose of this study was to analyze the research trends of randomized controlled trials on herbal medicine treatment for atopic dermatitis in China for the last 5 years. We searched for randomized controlled trials with the intervention of herbal medicine for the treatment of atopic dermatitis in the CNKI (China National Knowledge Infrastructure) from January 2014 to December 2018. For the screening of the paper, we used '特应性皮炎' and '异位性皮炎' which mean atopic dermatitis and search was limited to three areas within Medicine & Public Health: Traditional Chinese Medicine, Traditional Chinese Medicinal Herbs, Combination of Traditional Chinese Medicine with Western Medicine. Among the 136 searched studies, we selected a total of 34 studies and analyzed a year of publication, subject characteristics, study design and intervention, prescribed herbal medicine and herbs, pattern identification, evaluation criteria, and outcomes. Longmu decoction (龍牡湯) and Polia Sclerotium (茯笭) was the most frequently prescribed medicine and herb. The most commonly used pattern identification was Blood deficiency and Wind-dryness (血虛風燥), and among them, the most frequently prescribed herb is Rehmanniae Radix (生地黃). In most studies using the total effectiveness and SCORAD index as an outcome measure, the herbal medicine treatment group showed statistically better results than the control group. As a result of the safety assessment, the herbal medicine treatment group was reported having significantly fewer side effects compared to the control group. Hence, it was confirmed that the intervention including herbal medicine had a significant effect on atopic dermatitis. This study would be able to provide the basis of clinical research on atopic dermatitis and applied to the treatment of atopic dermatitis.

교량공사 제3자 피해 손실에 의한 리스크 분석 연구 (A Study on Bridge Construction Risk Analysis for Third-Party Damage)

  • 안성진;남경용
    • 한국건축시공학회지
    • /
    • 제20권2호
    • /
    • pp.137-145
    • /
    • 2020
  • 최근 교량은 장대화, 신공법의 도입에 따른 위험요인의 증가로 교량공사에서의 철저한 안전 및 리스크 관리 체계가 필요하다. 공사 현장 주변에 있는 발주자 건설공사 관련자 및 공사와 관련이 없는 제 3자의 기존 재산에 손해를 발생시킬 수 있어 제3자 피해 손실로 인한 리스크가 명확히 분석되어야 함에도 불구하고 연구가 미비한 실정이다. 본 연구는 교량건설 사업에 대한 국내 주요 보험사의 과거 보험료 지급 실적을 토대로 실제 교량 건설에서 제3자 피해 손실로 인한 손실에 대한 교량건설 특성에 따른 리스크 요인을 분석하고, 정량화된 예측 손실 모델을 개발하고자 하였다. 정량적 교량건설 손실모형 개발을 위해 사고 건당 보험지급액을 총공사비로 나눈 손실비율을 종속변수로 선정하였고, 상부구조, 하부구조, 홍수 및 도급순위가 교량건설 중 제3자 피해에 의한 손실비율에 영향을 미치는 지표로 나타났다. 도출된 결과는 건설프로젝트에 대한 손실 평가 모델 개발에 기존의 프로젝트 내부에서 발생한 손실과 더불어 제3자 피해손실을 고려함으로써 더불어 균형 있는 리스크 평가에 필수적인 지침으로 활용할 수 있다.

충격소음으로 인한 양식어류 피해기준 제안 (Suggestion of Safety Level in Fish Farming by Impulsive Sound)

  • 최태홍;김정한;송하림;고진석
    • 터널과지하공간
    • /
    • 제25권2호
    • /
    • pp.125-132
    • /
    • 2015
  • 어류 양식장 인근에서 건설공사로 인하여 발생하는 소음 진동의 경우 피해 금액과 산정방식 선정은 건설공사에 대한 공종별 전문가의 공학적, 기술적 의견이 배제된 상태에서 이루어지고 있다. 피해자 측이 일방적으로 어류 전문가들의 생물학적 자문 위주의 논리만 주장하는 반면, 어류에 대한 생물학적 전문지식이 부족한 건설사 측은 일반적인 건설소음 진동에 관한 논리를 전개하는 경우가 대부분이다. 그래서 중앙 환경 분쟁 조정위원회에서는 2009년 소음 진동으로 인한 육상 양식어류 피해 평가 및 배상액 산정기준에 관한 연구를 통해 구체적인 피해기준을 제시하였다. 국내의 경우 수중소음 피해인정 기준을 140 dB re $1{\mu}Pa$을 인정하고 있다. 이 기준은 충격음이 아닌 1초 이상의 연속음의 RMS 값이다. 또한, 기존 연구 자료들을 보면 어류는 골표류와 비골표류, 기각류와 비기각류 등 어종에 따라서 수중소음에 대한 반응이 많은 차이가 있는 것으로 보인다. 그래서 본 연구는 충격음과 연속음의 특성 차이를 고려하여 충격음의 피해기준을 제시하려 한다.

Change of Fractured Rock Permeability due to Thermo-Mechanical Loading of a Deep Geological Repository for Nuclear Waste - a Study on a Candidate Site in Forsmark, Sweden

  • Min, Ki-Bok;Stephansson, Ove
    • 한국방사성폐기물학회:학술대회논문집
    • /
    • 한국방사성폐기물학회 2009년도 학술논문요약집
    • /
    • pp.187-187
    • /
    • 2009
  • Opening of fractures induced by shear dilation or normal deformation can be a significant source of fracture permeability change in fractured rock, which is important for the performance assessment of geological repositories for spent nuclear fuel. As the repository generates heat and later cools the fluid-carrying ability of the rocks becomes a dynamic variable during the lifespan of the repository. Heating causes expansion of the rock close to the repository and, at the same time, contraction close to the surface. During the cooling phase of the repository, the opposite takes place. Heating and cooling together with the, virgin stress can induce shear dilation of fractures and deformation zones and change the flow field around the repository. The objectives of this work are to examine the contribution of thermal stress to the shear slip of fracture in mid- and far-field around a KBS-3 type of repository and to investigate the effect of evolution of stress on the rock mass permeability. In the first part of this study, zones of fracture shear slip were examined by conducting a three-dimensional, thermo-mechanical analysis of a spent fuel repository model in the size of 2 km $\times$ 2 km $\times$ 800 m. Stress evolutions of importance for fracture shear slip are: (1) comparatively high horizontal compressive thermal stress at the repository level, (2) generation of vertical tensile thermal stress right above the repository, (3) horizontal tensile stress near the surface, which can induce tensile failure, and generation of shear stresses at the comers of the repository. In the second part of the study, fracture data from Forsmark, Sweden is used to establish fracture network models (DFN). Stress paths obtained from the thermo-mechanical analysis were used as boundary conditions in DFN-DEM (Discrete Element Method) analysis of six DFN models at the repository level. Increases of permeability up to a factor of four were observed during thermal loading history and shear dilation of fractures was not recovered after cooling of the repository. An understanding of the stress path and potential areas of slip induced shear dilation and related permeability changes during the lifetime of a repository for spent nuclear fuel is of utmost importance for analysing long-term safety. The result of this study will assist in identifying critical areas around a repository where fracture shear slip is likely to develop. The presentation also includes a brief introduction to the ongoing site investigation on two candidate sites for geological repository in Sweden.

  • PDF

2008년부터 2019년까지 수행된 국제공동연구 DECOVALEX 소개 (Introduction of International Cooperation Project, DECOVALEX from 2008 to 2019)

  • 이창수;김태현;이재원;박정욱;권새하;김진섭
    • 터널과지하공간
    • /
    • 제30권4호
    • /
    • pp.271-305
    • /
    • 2020
  • 열-수리-역학-화학적 복합거동의 영향은 고준위방사성폐기물 심층 처분시스템의 성능평가 및 안전성 평가 측면에서 중요하기 때문에 이를 분석하고 예측하기 위한 해석모델과 수치해석 기법이 필요하다. 하지만, 장기간에 걸쳐 발생하는 열-수리-역학-화학적 복합거동에 관련된 다양한 현상들이 비선형적 거동을 보이고 그 구성방정식들의 상관관계가 명확하지 않기 때문에 이를 정확하게 해석하고 예측할 수 있는 수치모델과 모델링 기법을 개발하는 것은 매우 어렵다. 뿐만 아니라, 개발된 수치모델과 모델링 기법을 검증하기 위해서는 오랜 시간동안 수행되어야 하는 고비용의 실험실 시험과 현장시험이 필요하기 때문에 열-수리-역학-화학적 복합거동 분석과 예측을 위한 수치모델과 모델링 기법의 개발뿐만이 아니라 검증 역시 쉽지 않다. 이러한 문제를 해결하여 효과적인 수치모델 및 해석기법 개발과 실험실 시험 및 현장시험 데이터를 활용한 검증을 수행하기 위해 국제공동연구 DECOVALEX(DEvelopment of COupled models and their VALidation against EXperiment) 프로젝트가 1992년부터 시작되었다. 한국의 경우, 한국원자력연구원이 2008년부터 DECOVALEX-2011, DECOVALEX-2015, 그리고 DECOVALEX-2019에 참여하였다. 본 기술 보고에서는 지난 3단계의 DECOVALEX 프로젝트에서 수행된 모든 과제의 주요 내용을 국내 암반 및 지반공학자들에게 소개하였다.

한국인의 식이를 통한 보존료의 일일추정섭취량과 안전성평가 (Assessment of Estimated Daily Intakes of Preservatives in the Korean Population)

  • 최성희;이지연;박은영;원준;홍기형;문귀임;김민식;홍진환
    • 한국식품과학회지
    • /
    • 제40권5호
    • /
    • pp.503-509
    • /
    • 2008
  • 국내 사용빈도가 높은 소르빈산류, 안식향산류, 파라옥시안식향산에스터류의 일일추정섭취량을 평가하였다. 식품별 보존료 농도와 국민건강 영양조사의 성별, 연령별 식품섭취자료와 체중을 이용하여 일일추정섭취량을 산출하였고, 이를 JECFA에서 제시한 ADI와 비교 검토하여 안전성 여부를 평가하였다. 분석된 보존료의 일일추정섭취량은 소르빈산류 495.85 ${\mu}g$/kg bw/day, 안식향산류 215.34 ${\mu}g$/kg bw/day, 파라옥시안식향산에스터류 5.01 ${\mu}g$/kg bw/day로 산출되었으며, ADI 대비 각각 2, 4.3, 0.1%로 섭취 수준은 안전한 것으로 평가되었다. 상위섭취자(90th)의 일일추정 섭취량은 소르빈산류 1,012.06 ${\mu}g$/kg bw/day, 안식향산류 229.56 ${\mu}g$/kg bw/day, 파라옥시안식향산에스터류 11.58 ${\mu}g$/kg bw/day로 산출되었으며 ADI 대비 4.1, 4.6, 0.1%로 안전한 섭취수준으로 평가되었다. 성별에 따른 차이는 안식향산류의 경우 남자가 여자보다 많이 섭취하였으나 소르빈산류와 파라옥시안식향산에스터류는 성별에 따른 차이를 보이지 않았다. 소르빈산류, 안식향산류, 파라옥시안식향산류의 일일추정섭취량은 모든 연령에서 안전한 섭취수준으로 평가되었다.

A Case Series of Survival Outcomes in Patients with Advanced-stage IIIb/IV Non-small-cell Lung Cancer Treated with HangAm-Plus

  • Bang, Sun-Hwi;Yoon, Jeung-Won;Cho, Chong-Kwan;Shin, Ji-Eun;Lee, Yeon-Weol;Yoo, Hwa-Seung
    • 대한약침학회지
    • /
    • 제15권2호
    • /
    • pp.31-35
    • /
    • 2012
  • Background and Objectives: Non-small-cell lung cancer (NSCLC) represents approximately 80% of all lung cancers. Unfortunately, at their time of diagnosis, most patients have advanced to unresectable disease with a very poor prognosis. The oriental herbal medicine HangAm-Plus (HAP) has been developed for antitumor purposes, and several previous studies have reported its therapeutic effects. In this study, the efficacy of HAP was evaluated as a third-line treatment for advanced-stage IIIb/IV NSCLC. Methods: The study involved six patients treated at the East- West Cancer Center (EWCC) from April 2010 to October 2011. Inoperable advanced-stage IIIb/IV NSCLC patients received 3,000 or 6,000 mg of HAP on a daily basis over a 12-week period. Computed tomography (CT) scans were obtained from the patients at the time of the initial administration and after 12 weeks of treatment. We observed and analyzed the patients overall survival (OS) and progression-free survival (PFS). Results: Of the six patients, three expired during the study, and the three remaining patients were alive as of October 31, 2011. The OS ranged from 234 to 512 days, with a median survival of 397 days and a one-year survival rate of 66.7%. In the 12-week-interval chest CT assessment, three patients showed stable disease (SD), and the other three showed progressive disease (PD). The PFS of patients ranged from 88 to 512 days, the median PFS being 96 days. Longer OS and PFS were correlated with SD. Although not directly comparable, the OS and the PFS of this study were greater than those of the docetaxel or the best supportive care group in other studies. Conclusion: HAP may prolong the OS and the PFS of inoperable stage IIIb/IV NSCLC patients without significant adverse effects. In the future, more controlled clinical trials with larger samples from multi-centers should be conducted to evaluate the efficacy and the safety of HAP.